The US Food and Drug Administration (FDA) has approved a booster dose of Pfizer to people over 65, as well as people at high risk of serious illness, and those who are exposed to the virus. This is mentioned in the statement on the agency's website.
“Today’s action demonstrates that science and the currently available data continue to guide the FDA’s decision-making for COVID-19 vaccines during this pandemic. After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for a booster dose in certain populations,” it says.
The booster dose should be given at least six months after the second dose of Pfizer.
Earlier, the FDA supported booster vaccination with Pfizer, but at that time the organization has not made a final decision. Then the third dose was recommended for people over 65 years. Experts also recommended that those in the high-risk group be vaccinated with the third dose.
The US president wants to start booster doses of most people who received the Pfizer vaccine at the end of this month.
Besides, WHO director general Tedros Adhanom Ghebreyesus said that Covid-19 booster shots should be delayed as priority should be given to raising vaccination rates in poor countries.